http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105456293-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cdcd39df6d957de1404fc9049965fcc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66db3e1c9a7842f23b8dc80cf2b89d35 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44 |
| filingDate | 2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56007bc5643de19b4d34907d81648996 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abb4cd669f3fb705ba088d58d0b0bed8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68ee58dee69196568f02282839756061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76518b742c213ca6edccc1bf84ec7e8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39cb00eced240d1a6bef0f98e2c27981 |
| publicationDate | 2016-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105456293-A |
| titleOfInvention | Stem cell-based medicinal product for treating diabetes and preparing method thereof |
| abstract | The invention discloses a stem cell-based medicinal product for treating diabetes. The stem cell-based medicinal product contains mesenchymal stem cells separated and extracted from the human umbilical cord, the expression of stem cell surface markers CD73, CD90 and CD105 is higher than 95%, and the expression of cell surface markers CD14, CD34, CD45, CD19 and HLA-DR is lower than 3%. The stem cell-based medicinal product can be differentiated into pancreatic beta cells under induction, so that insulin is secreted and blood sugar concentration is effectively reduced, and then a new method is provided for overcoming the defect that diabetes treatment depends on insulin and radically curing diabetes. The invention further provides a method for preparing the stem cell-based medicinal product. The method is easy to operate, raw material sources are wide, ethic limitation is avoided, and large-scale production can be conducted. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114939157-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023038161-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106620704-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107460158-A |
| priorityDate | 2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.